Pneumocystis jirovecii pneumonia medical therapy: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{Pneumocystis jirovecii pneumonia}}{{CMG}} ==Overview== ==References== {{reflist|2}} {{WH}} {{WS}} Category:Disease Category:Infectious disease") |
No edit summary |
||
Line 1: | Line 1: | ||
{{Pneumocystis jirovecii pneumonia}}{{CMG}} | {{Pneumocystis jirovecii pneumonia}}{{CMG}} | ||
==Overview== | ==Overview== | ||
[[Trimethoprim-sulfamethoxazole]] is the drug of choice. Recommended alternatives include [[pentamidine]]; [[trimethoprim]] plus[[dapsone]]; [[atovaquone]]; and [[primaquine]] plus [[clindamycin]]. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 19:02, 7 February 2012
Pneumocystis jirovecii pneumonia Microchapters |
Differentiating Pneumocystis jirovecii pneumonia from other Diseases |
Diagnosis |
Treatment |
Case Studies |
Pneumocystis jirovecii pneumonia medical therapy On the Web |
American Roentgen Ray Society Images of Pneumocystis jirovecii pneumonia medical therapy |
Pneumocystis jirovecii pneumonia medical therapy in the news |
Risk calculators and risk factors for Pneumocystis jirovecii pneumonia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Trimethoprim-sulfamethoxazole is the drug of choice. Recommended alternatives include pentamidine; trimethoprim plusdapsone; atovaquone; and primaquine plus clindamycin.